Effect of age on the profile of alkanes in normal human breath

Free Radical Research

Volumn 33, Issue 1, 2000, Pages 57-63

  Phillips, Michael ^a,b,c   Greenberg, Joel ^b   Cataneo, Renee N ^b  

^a MENSSANA RESEARCH INC   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Alkane; Breath; Cytochrome p450; Free radical; Human; Oxidative stress; Reactive oxygen free species; Volatile organic compounds

Indexed keywords

ALKANE; CYTOCHROME P450; ETHANE; FREE RADICAL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PENTANE; REACTIVE OXYGEN METABOLITE; VOLATILE ORGANIC COMPOUND;

ADULT; AGE; AGED; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; METABOLISM; NORMAL HUMAN; OXIDATIVE STRESS; SEX DIFFERENCE;

EID: 0034036921     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300611     Document Type: Article

References (32)

1. I. Fridovich (1978): The biology of oxygen radicals. Science 201: 875-80.
2. C.M.F. Kneepkens, C. Ferreira, G. Lepage and C.C. Roy (1992): The hydrocarbon breath test in the study of lipid peroxidation: Principles and practice. Clinical Investigation Medicine 15: 163-86.
3. C.M.F. Kneepkens, G. Lepage and C.C. Roy (1994): The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radical Biology and Medicine 17:127-60.
4. W.A. Pryor (1993): Measurement of oxidative stress status in humans. Cancer Epidemiology Biomarkers and Prevention 2: 289-92.
5. G.A. Cortopassi and A. Wong (1999): Mitochondria in organismal aging and degeneration. Biochimica et Biophysica Acta 1410: 183-93.
6. T. Von Zglinicki (1998): Telomeres: Influencing the rate of aging. Annals of the New York Academy of Sciences 854: 318-27.
7. B. Halliwell, J.M.C. Gutteridge and C.E. Cross (1992): Free radicals, antioxidants, and human disease: Where are we now? Journal of Laboratory and Clinical Medicine 119: 598-620.
8. E. Hietanen, H. Bartsch, J.-C. Bereziat, A.-M. Camus, S. McClinton, O. Eremin, L. Davidson and P. Boyle (1994): Diet and oxidative stress in breast, colon and prostate cancer patients: A case control study. European Journal of Clinical Nutrition 48: 575-86.
9. P.A. Sobotka, D.K. Gupta, D.M. Lanskv, M.R. Costanzo and E.J. Zarling (1994): Breath pentane is a marker of acute cardiac allograft rejection. Journal of Heart Lung Transplantation 13: 224-9.
10. Z.W. Weitz, A.J. Birnbaum, P.A. Sobotka, E.J. Zarling and J.L. Skosey (1991): High breath pentane concentrations during acute myocardial infarction. Lancet 337: 933-5.
11. E.S. Kovaleva, O.N. Orlov, Mia Tsutsul'kovskaia, T.V. Vladimirova and B.S. Beliaev (1989): Lipid peroxidation processes in patients with schizophrenia. Zh Neuropatol Psikiatr 89: 108-10.
12. S. Humad, E. Zarling, M. Clapper and J.L. Skosey (1988): Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free Radical Research Communications 5: 101-6.
13. C.O. Olopade, M. Zakkar, W.I. Swedler and I. Rubinstein (1997): Exhaled pentane levels in acute asthma. Chest 111: 862-5.
14. M. Phillips, K. Gleeson, J.M.B. Hughes, J. Greenberg, R.N. Cataneo, L. Baker and W.P. McVay (1999): Volatile organic compounds in breath as markers of lung cancer: A cross-sectional study. Lancet 353: 1930-33.
15. A. Cailleux and P. Allain (1993): Is pentane a normal constituent of human breath? Free Radical Research Communications 18: 323-7.
16. M. Phillips, J. Greenberg and J. Awad (1994): Metabolic and environmental origins of volatile organic compounds in breath. Journal of Clinical Pathology 47: 1052-3.
17. M. Phillips, M. Sabas and J. Greenberg (1994): Alveolar gradient of pentane in normal human breath Free Radical Research Communications 20: 333-7.
18. M. Phillips, J. Herrera, S. Krishnan, M. Zain, J. Greenberg and R.N. Cataneo (1999): Variation in volatile organic compounds in the breath of normal humans. Journal of Chromatography B 629: 75-88.
19. M. Phillips (1997): Method for the collection and assay of volatile organic compounds in breath. Analytical Biochemistry 247: 272-8.
20. E.J. Zarling, S. Mobarhan, P. Bowen and S. Kamath (1993): Pulmonary pentane excretion increases with age in healthy subjects. Mechanisms of Ageing and Development 67: 141-7.
21. M. Jones, N. Shiel, M. Summan, N.M. Sharer, C. Hambleton, M. Super and J.M. Braganza (1993): Application of breath pentane analysis to monitor age-related change in free radical activity. Biochemical Society Transactions 21: 485S.
22. M. Sagai and T. Ichinose (1980): Age-related changes in lipid peroxidation as measured by ethane, ethylene, butane and pentane in respired gases of rats. Life Sciences 27: 731-8.
23. S.J. Crosbie, P.G. Blaine and F.M. Williams (1997): Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers. Human and Experimental Toxicology 16: 131-7.
24. U. Scheller, T. Zimmer, E. Kargel and W.H. Schunck (1996): Characterization of the n-alkane and fatty acid hydroxylating cytochrome P-450 forms 52A3 and 52A4. Archives of Biochemistry and Biophysics 328: 245-54.
25. J. George, K. Byth and G.C. Farrell (1995): Age but not gender selectively affects expression of individual cytochrome p450 proteins in human liver. Biochemical Pharmacology 50: 727-30.
26. E.A. Sotaniemi, A.J. Arranto, O. Pelkonen and M. Pasanen (1997): Age and cytochrome p450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions. Clinical Pharmacology and Therapeutics 61: 331-9.
27. E. Tanaka (1998): In view age-related changes in hepatic drug-oxidizing capacity in humans. Journal of Clinical Pharmacology and Therapeutics 23: 247-55.
28. K.P. Charpentier, L.L. von Moltke, J.W. Poku, J.S. Harmatz, R.I. Shader and D.J. Greenblatt (1997): Alprazolam hydroxylation by mouse liver microsomes in vitro: The effect of age and phenobarbital induction. Biopharmacy and Drug Disposition 18: 139-49.
29. D. Williams and K. Woodhouse (1995): The relationship between age and cutaneous aryl hydrocarbon hydroxylase (AHH) activity. Age and Ageing 24: 213-6.
30. J.T. James, T.F. Limero, H.J. Leano, J.F. Boyd and P.A. Covington (1994): Volatile organic contaminants found in the habitable environment of the space shuttle: STS-26 to STS-55. Aviation, Space and Environmental Medicine 65: 851-7.
31. U. Troger and F.P. Meyer (1995): Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation. Clinical Pharmacokinetics, 28: 287-314.
32. D. Kohlmuller and W. Kochen (1993): Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. Analytical Biochemistry 210: 266-76.